(CIDRAP News) – Predicting that 44% of this year's supply of influenza vaccine won't be available until November and December, federal health officials are recommending that vaccine doses available in October be reserved for healthcare workers and people who have an increased risk of influenza complications.
(CIDRAP News) The federal government is considering buying influenza vaccine from a British company in an effort to remedy a possible shortage in the United States, the head of the Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) The World Health Organization (WHO) said today it is launching an effort to quickly develop a vaccine against influenza A(H5N1), the avian flu virus that has caused at least five human deaths in Vietnam.
(CIDRAP News) The Food and Drug Administration (FDA) has completed its recommendations for next season's influenza vaccine, calling for inclusion of the A Fujian viral strain that caused most flu cases in the United States this winter.
(CIDRAP News) In a bid to limit the threat of an influenza pandemic, the Department of Health and Human Services (HHS) is awarding a contract to Aventis Pasteur Inc. to make 2 million doses of a vaccine for humans to protect against H5N1 avian influenza.
(CIDRAP News) The vaccine supply for the soon-to-begin influenza season is suddenly in serious condition with news that Chiron Corp., maker of about half the US supply, has been ordered to stop production by British health authorities and will not be shipping its doses.
(CIDRAP News) Lester Crawford, acting director of the US Food and Drug Administration (FDA), appearing before the House Committee on Government Reform yesterday, said he was pessimistic about the possiblility that any of the 48 million doses of influenza vaccine expected in the United States from Chiron Corp. can be salvaged for use this flu season, according to new service reports.
(CIDRAP News) To cope with the loss of nearly half of the nation's influenza vaccine supply, federal health officials and Aventis Pasteur announced plans today to distribute Aventis's 22.4 million remaining doses to those who need them the most.
(CIDRAP News) Federal health officials today ruled out using any of Chiron Corporation's influenza vaccine in the United States this year, following the completion of inspections at the company's plant in Liverpool, England.